TREATMENT OF THE ANEMIA OF HEMODIALYSIS-PATIENTS WITH RECOMBINANT HUMAN ERYTHROPOIETIN

被引:31
作者
SCHAEFER, RM [1 ]
KUERNER, B [1 ]
ZECH, M [1 ]
DENNINGER, G [1 ]
BORNEFF, C [1 ]
HEIDLAND, A [1 ]
机构
[1] CILAG GMBH, ALSBACH HAHNLEIN, GERMANY
关键词
D O I
10.1177/039139888801100407
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
引用
收藏
页码:249 / 254
页数:6
相关论文
共 23 条
[1]   KIDNEY AND ERYTHROPOIESIS [J].
ADAMSON, JW ;
ESCHBACH, J ;
FINCH, CA .
AMERICAN JOURNAL OF MEDICINE, 1968, 44 (05) :725-+
[2]  
ASABA H, 1977, CLIN NEPHROL, V8, P304
[3]   EFFECT OF PARATHYROIDECTOMY ON ANEMIA IN CHRONIC RENAL-FAILURE [J].
BARBOUR, GL .
ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (08) :889-891
[4]  
BOMMER J, 1987, Nephrology Dialysis Transplantation, V2, P238
[5]   BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS [J].
CASATI, S ;
PASSERINI, P ;
CAMPISE, MR ;
GRAZIANI, G ;
CESANA, B ;
PERISIC, M ;
PONTICELLI, C .
BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605) :1017-1020
[6]   THE ANEMIA OF CHRONIC-RENAL-FAILURE IN SHEEP - RESPONSE TO ERYTHROPOIETIN-RICH PLASMA INVIVO [J].
ESCHBACH, JW ;
MLADENOVIC, J ;
GARCIA, JF ;
WAHL, PW ;
ADAMSON, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (02) :434-441
[7]   ANEMIA OF END-STAGE RENAL-DISEASE (ESRD) [J].
ESCHBACH, JW ;
ADAMSON, JW .
KIDNEY INTERNATIONAL, 1985, 28 (01) :1-5
[8]   CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].
ESCHBACH, JW ;
EGRIE, JC ;
DOWNING, MR ;
BROWNE, JK ;
ADAMSON, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78
[9]   MEGALOBLASTIC HEMATOPOIESIS IN UREMIA AND IN PATIENTS ON LONG-TERM HEMODIALYSIS [J].
HAMPERS, CL ;
STREIFF, R ;
NATHAN, DG ;
SNYDER, D ;
MERRILL, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (10) :551-&
[10]   HUMAN RECOMBINANT ERYTHROPOIETIN PROMOTES DIFFERENTIATION OF MURINE MEGAKARYOCYTES INVITRO [J].
ISHIBASHI, T ;
KOZIOL, JA ;
BURSTEIN, SA .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (01) :286-289